Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-09-29

Clinical Trial Update: Efficacy - Safety of Eflornithine-Nifurtimox Combination Versus Eflornithine to Treat Human African Trypanosomiasis [Phase 3]

View source ↗

Summary

Phase 3 results compare the efficacy and safety of the eflornithine-nifurtimox combination versus eflornithine alone in human African trypanosomiasis; the trial…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Eflornithine (eflornithine)
  • Nifurtimox (Nifurtimox)

Snippet

Sponsor: Drugs for Neglected Diseases | Conditions: Trypanosomiasis, African | Phase 3 | Status: COMPLETED